The World of S+R

Facial Aesthetic Priorities and Concerns: A Physician and Patient Perception Global Survey

Aesthetic Surgery Journal – April 2022 (NSS) The objective of this survey was to examine and understand facial aesthetic priorities, concerns, and treatment goals across varied geographical regions in aesthetically conscious adult respondents and physicians and to apply these insights toward optimizing practitioner–patient aesthetic consultation, treatments, and ultimately patient satisfaction. Read More

#Botox 101: Subgroup Analysis of Twitter’s Top 101 Neurotoxin Influencers

Recent studies demonstrate that board-certified plastic surgeons and dermatologists are underrepresented in posting public-directed marketing content about botulinum toxin A on YouTube. However, educational content and peer-to-peer social media influence regarding the topic of neurotoxins has not been studied. Twitter is a social media platform that has emerged as a unique network for public education […]

The Principles and Practice of Endonasal Rhinoplasty

Endonasal rhinoplasty is not the same as open rhinoplasty performed through a keyhole. The mindset is different and it is a “right-brain” endeavor, that is, one in which the surgeon must translate many complex esthetic concepts into a unified vision for the end result. How to arrive at the “right” unified vision is the exercise […]

The Millennial Mindset

The U.S. Census Bureau defines the Millennial generation as those born between 1982 and 2000, placing the upper age range at 36 years old. The largest generation in US history, outnumbering Baby Boomers and representing more than one-quarter of the US population, they are poised to reshape the economy. They are outspending Baby Boomers 2 […]

“Millennial Botulinum Toxin”: A Retrospective Age-Matched Cohort Study With OnabotulinumtoxinA

This study examines onabotulinumtoxinA dosing in Millenials and an older cohort in clinical practice, and compares this to Food and Drug Administration (FDA) approved dosing for 3 aesthetic subunits. Read More

Learning Curves: Historical Trends of FDA-Reported Adverse Events for Dermal Fillers

Dermal fillers are considered Class III medical devices by the US Food and Drug Administration (FDA).1 Reports of adverse events (AEs) for medical devices are made public by the FDA to allow for transparent postmarketing surveillance.2The AE trends extracted from these historical data may help distinguish between expected learning curves of new dermal fillers versus […]